Receptos to Present at Jefferies 2013 Global Healthcare Conference
29 Maggio 2013 - 10:30PM
Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company
developing therapeutic candidates for the treatment of immune and
metabolic diseases, today announced that its President and Chief
Executive Officer, Faheem Hasnain, will be presenting at the
Jefferies 2013 Global Healthcare Conference at the Grand Hyatt
Hotel in New York City. The presentation is scheduled for
Wednesday, June 5, 2013, at 9:30 am Eastern Time. To
listen to the live webcast or a replay of the presentation, please
visit the Investor Relations section of the Company's website at
www.receptos.com. A replay will be available for 14 days after the
event.
About Receptos
Receptos is a biopharmaceutical company developing therapeutic
candidates for the treatment of immune and metabolic diseases. The
Company's lead program, RPC1063, is a sphingosine 1-phosphate 1
receptor (S1P1R) small molecule modulator candidate for immune
indications, including relapsing multiple sclerosis (RMS) and
inflammatory bowel disease (IBD). The Company is also developing
RPC4046, an anti-interleukin-13 (IL-13) antibody for an
allergic/immune-mediated orphan disease, eosinophilic esophagitis
(EoE). Receptos has established expertise in high resolution
protein crystal structure determination, biology and drug discovery
for G-protein-coupled receptors (GPCRs).
CONTACT: Media and Investor Contact:
Graham K. Cooper
Chief Financial Officer, Receptos
(858) 652-5708
gcooper@receptos.com
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a (MM) (NASDAQ): 0 articoli recenti
Più Receptos, Inc. Articoli Notizie